Neuroblastoma History

NewsGuard 100/100 Score

Neuroblastoma describes a cancer of the developing, immature neural cells found in the embryo or fetus, called neuroblasts. This condition was first described in 1864 by the German physician Rudolf Virchow who called the tumors he found in the abdomens of children gliomas.

It was in 1891 that German pathologist Felix Marchand first noted the features of the tumors developing in the sympathetic nervous system and the adrenal medulla that lies over the kidneys. Stage four (4S) neuroblastoma, which is characterized by spread to the liver but not the bone was described by William Pepper in 1901.

In 1910, James Homer Wright noted that these tumors originated from in an immature, primitive form of neural cell and he therefore named the tumors neuroblasts, as "blastoma" refers to a collection of immature, undifferentiated cells. Wright also documented the formation of round clumps of cells in samples of bone marrow and these are now commonly referred to as "Homer-Wright pseudorosettes."

In 1914, Herxheimer went on to show that within the tumors of neuroblastomas, special silver stains could highlight the neuronal fibrils allowing the cancer to be visualized under the microscope.

In 1927, Cushing and Wolbach found that not all neuroblastomas were cancerous and while some were malignant and spread rapidly to various organs in the body such as the liver, skin, bone and bone marrow, others resolved independently of treatment.

In some rare cases, they found that the tumors turned into non-malignant or benign masses called ganglioneuromas, which may also resolve on their own. Everson and Cole added that the transformation from cancerous to non-cancerous forms was rare in babies over 6 months of age.

In 1957 Mason discovered that the presence of catecholamines could be detected in the urine of children with neuroblastoma. Cathecholamines are hormones that are produced in high quantities by the tumors, providing a marker for presence of the illness.

Sources

  1. Virchow R. Hyperplasie der Zirbel und der Nebennieren. In: Die Krankhaften Geschwulste. Vol 2. 1864-65.
  2. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1931802/
  3. Everson TC, Cole WH. Spontaneous regression of neuroblastoma. In: Everson TC, Cole WH, eds.Spontaneous Regression of Cancer. Philadelphia, Pa: WB Saunders; 1966:88.
  4. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949785/
  5. www.thelancet.com/.../fulltext

Further Reading

Last Updated: Feb 27, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, February 27). Neuroblastoma History. News-Medical. Retrieved on April 23, 2024 from https://www.news-medical.net/health/Neuroblastoma-History.aspx.

  • MLA

    Mandal, Ananya. "Neuroblastoma History". News-Medical. 23 April 2024. <https://www.news-medical.net/health/Neuroblastoma-History.aspx>.

  • Chicago

    Mandal, Ananya. "Neuroblastoma History". News-Medical. https://www.news-medical.net/health/Neuroblastoma-History.aspx. (accessed April 23, 2024).

  • Harvard

    Mandal, Ananya. 2019. Neuroblastoma History. News-Medical, viewed 23 April 2024, https://www.news-medical.net/health/Neuroblastoma-History.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.